Keyword: generics

News

Teva and Takeda in Japanese Generics JV

01.12.2015 - Israeli generics giant Teva and Japanese drugmaker Takeda have agreed to form a partnership to address the growing importance of generics in Japan. The 51:49 joint venture, which...

News

Imprimis Touts Cheaper Daraprim Alternative

26.10.2015 - California-based Imprimis Pharmaceuticals is touting a customizable compounded formulation of pyrimethamine and leucovorin as a low cost alternative to Daraprim, the drug that made...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

News

FDA Approves Mylan’s Yasmin Copies

11.09.2015 - Following approval from the US Food and Drug Administration (FDA), Netherlands-domiciled Mylan has launched generic copies of Bayer's drospirenone and ethinyl estradiol-based...

News

Mylan Makes New Bid for Perrigo

10.09.2015 - Mylan has announced a fresh $27.14 billion offer for generic drug and ingredients maker Perrigo. The Ireland-based drugmaker previously rejected several offers from its Netherlands...

Strategy & Management

Significant Value Creation

03.09.2015 - In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...

News

Perrigo Acquires Scar Management Brand

02.09.2015 - Fresh from completing its acquisition of GlaxoSmithKline’s OTC business, Ireland-domiciled pharmaceutical producer Perrigo has acquired ScarAway, a leading OTC scar management...

News

Lilly Wins Court Ruling on Alimta Patent

27.08.2015 - A court in Indiana, USA, has ruled in Eli Lilly’s favor in a long-running patent battle with Teva Pharmaceutical Industries relating to infringement of the vitamin regimen for its...